Birchview Capital, LP - 23 Mar 2023 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
10%+ Owner
Signature
Birchview Capital, LP By: /s/ Matthew Strobeck Matthew Strobeck, Managing Member of Birchview Capital GP, LLC, General Partner of Birchview Capital, LP
Issuer symbol
ELUT
Transactions as of
23 Mar 2023
Net transactions value
+$206,958
Form type
4
Filing time
27 Mar 2023, 16:17:11 UTC
Previous filing
13 Feb 2023
Next filing
20 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELUT Class A Common Stock Purchase $149,100 +100,000 +6.6% $1.49 1,615,184 23 Mar 2023 See footnote F1, F2
transaction ELUT Class A Common Stock Purchase $14,910 +10,000 +0.62% $1.49 1,625,184 23 Mar 2023 See footnote F1, F3
transaction ELUT Class A Common Stock Purchase $24,370 +18,000 +1.1% $1.35 1,643,184 24 Mar 2023 See footnote F1, F2
transaction ELUT Class A Common Stock Purchase $2,708 +2,000 +0.12% $1.35 1,645,184 24 Mar 2023 See footnote F1, F3
transaction ELUT Class A Common Stock Purchase $15,870 +10,000 +0.61% $1.59 1,655,184 27 Mar 2023 See footnote F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.
F2 The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.
F3 As specified in Table I, Birchview Capital, LP advises the acquired shares in a separately managed account ("SMA").
F4 As specified in Table I, Birchview Capital, LP advises the acquired shares in a different SMA other than the one noted above.